Desperate patients want a new ALS drug. The FDA is not sure it works.

·

·

Desperate patients want a new ALS drug. The FDA is not sure it works.

Today, those former students run the Cambridge-based biotech company Amylyx that is seeking Food and Drug Administration approval for the treatment, known as AMX0035. And Kowalski and other ALS patients are flooding the federal agency …
See Original Article

Law360 MVP Awards: Eight Sullivan & Cromwell Partners Named 2022 MVPs

Eight Sullivan & Cromwell partners have been named Law360 MVPs for “securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.” The Sullivan & Cromwell lawyers were selected from more than 900 …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.